https://www.selleckchem.com/pr....oducts/3-methyladeni
Acute antibody-mediated rejection (AAMR) is the subject of much research. It is diagnosed by C4d staining at biopsy and circulating donor-specific antibodies (DSA). The combination of intensive plasmapheresis and intravenous immunoglobulin (IVIG) has been recognized as an effective treatment for AAMR. We report our single-center experience on AAMR treatment. We treated 23 transplanted patients (group A) with protein-A immunoadsorption (IA) and 7 patients (group with double-filtration plasmapheresis. All patients were treated